P.A. Abrahamsson	Department of Urology, Skåne University Hospital, Lund University, Malmö, Sweden
B. B. Aggarwal	Inflammation Research Center, San Diego, CA, USA
T. Akimoto	Division of Partical Therapy and Department of Radiation Oncology, National Cancer Center East, Kashiwa, Chiba, Japan
P.Z. Anastasiadis	Department of Cancer Biology, Mayo Cancer Center, Jacksonville, FL, USA
A. Argiris	Division of Hematology/Oncology, UT Health Science Center at San Antonio, San Antonio, TX, USA
J. P. Armand	Institut Gustave Roussy, Paris, France
V. I. Avramis	Division of Hematology/Oncology, Childrens Hospital, Los Angeles, CA, USA
D.T. Bau	Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan
G. Bauer	Abteilung Virologie, Institut für Medizinische Mikrobiologie und Hygiene, Universität Freiburg, Freiburg, Germany
E. E. Baulieu	INSERM U488 and College de France, Le Kremlin-Bicetre, France
E. J. Benz, Jr.	Dana-Farber Cancer Institute, Boston, MA, USA
J. Bergh	Department of Clinical and Molecular Medicine, Radiumhemmet, Karolinska Institute, Stockholm, Sweden
J. Y. Blay	Centre Léon Bérard, Lyon, France
F. T. Bosman	Institute of Pathology, University of Lausanne,  Lausanne, Switzerland
M. Bouvet	Department of Surgery, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA
J. Boyd	Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida Int. University, Miami, FL, USA
G. Broich	Gruppo Policlinico di Monza, Monza, Italy
Ø. S. Bruland	Department of Medical Oncology-Radiotherapy, Norwegian Radium Hospital, Oslo, Norway
J.M. Buatti	Department of Radiation Oncology, University of Iowa, Iowa City, IA, USA
M. Carbone	Cancer Research Center of Hawaii, Honolulu, HI, USA
C. Carlberg	Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland
A. F. Chambers	Department of Oncology, London Regional Cancer Center, London, Ontario, Canada
P. Chandra	Abt. für Molekularbiologie, Klinikum Wolfgang Goethe-Universität, Frankfurt am Main, Germany
L. Cheng	Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA
J.-G. Chung	Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, ROC
R. Clarke	Department of Oncology, Georgetown University Medical Center, Washington, DC, USA
E. De Clercq	Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium
A. P. Conley	Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
E. P. Diamandis	Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
G. Th. Diamandopoulos	Department of Pathology, Harvard Medical School, Boston, MA, USA
J.M. Drake	Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA
L. Egevad	Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
D.W. Felsher	Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA
H. Fu	Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA
B. Fuchs	Balgrist University Hospital, Zurich, Switzerland
D. Fuchs	Center for Chemistry and Biomedicine, Innsbruck Medical University, Innsbruck, Austria
E. L. Fukumura	Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA
G. Gabbiani	Department of Pathology, University of Geneva, Geneva, Switzerland
R. Ganapathi	Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA
A. Giordano	Sbarro Institute for Cancer Research, Temple University, Philadelphia, PA, USA
M. Gnant	Department of Surgery, Medical University of Vienna, Vienna, Austria
R. H. Goldfarb	Trudeau Institute, Saranac Lake, NY, USA
J.S. Greenberger	Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA
A. Helland	Oslo University Hospital-Radium Hospital, Oslo, Norway
L. Helson	Sign Path Pharma, Inc., Quakertown, PA, USA
R. Henriksson	Department of Radiation Science, University of Umea, Umea, Sweeden
R. M. Hoffman	Department of Surgery, University of California, San Diego, CA, USA
P. Hohenberger	Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, Mannheim, Germany
F. Janku	Monte Rosa Therapeutics, Boston, MA, USA
S. C. Jhanwar	Laboratory of Solid Tumor Genetics, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J. V. Johannessen	Department of Pathology, the Norwegian Radium Hospital, Oslo, Norway
R. Jones	Sarcoma Unit, Royal Marsden Hospital, London, UK
B. Kaina	Institute of Toxicology, University of Mainz, Mainz, Germany
D. G. Kieback	Helios Medical Center Schleswig, Schleswig, Germany
R. Klapdor	Medical Clinic, University of Hamburg, Hamburg, Germany
K. L. Knutson	Mayo Clinic, Jacksonville, FL, USA
H. Kobayashi	Laboratory of Molecular Theranostics, NCI/NIH, Bethesda, MD, USA
S. D. Kottaridis	Department of Virology, Hellenic Anticancer Institute, Athens, Greece
G. R. F. Krueger	Center of Anatomy II, University of Cologne Medical School, Cologne, Germany
Pat Kumar	Department of Biological Sciences, Manchester Metropolitan University, Manchester, UK
Shant Kumar	Department Pathology, University of Manchester Medical School, Manchester, UK
O. D. Laerum	Department of Pathology, the Gade Institute, University of Bergen, Bergen, Norway
F. J. Lejeune	Fondation du Centre Pluridisciplinaire d’ Oncologie, CHUV, Lausanne, Switzerland
S. Linder	Department of Medicine and Health, Linköping University, Linköping, Sweden
D. M. Lopez	Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL, USA
E. Lundgren	Unit of Applied Cell and Molecular Biology, University of Umeå, Umeå, Sweden
Y. Maehara	Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
J. Maher	Department of Research Oncology, Division of Cancer Studies, King’s College London School of Medicine, Guy’s Hospital Campus, London, UK
J. Marescaux	IRCAD, University of Strasbourg, Strasbourg, France
S.S. Martin	Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, USA
S. Mitra	Houston Methodist Research Institute, Houston, TX, USA
S. Miyamoto	Department of Obstetrics and Gynecology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
S. Moncada	Manchester Cancer Research Centre, University of Manchester, Manchester, UK
M. Mueller	Hochschule Furtwangen University, Villingen-Schwenningen, Germany
M. Namiki	Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa City, Ishikawa, Japan
K. Nilsson	Rudbeck Laboratory, Department of Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden
S. Pathak	Department of Cell Biology, University of Texas, Houston, TX, USA
J.L. Persson	Section for Experimental Cancer Research, Clinical Research Center, Lund University, Malmö, Sweden
G. J. Pilkington	Department of Cellular and Molecules Neurooncology, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
C. D. Platsoucas	College of Sciences, Old Dominion University, Norfolk, VA, USA
A. Polliack	Department of Haematology, Hadassah University Hospital and Medical School, Jerusalem, Israel
D. Rades	Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
M. Rigaud	Laboratory Biochimie et Génétique Molecules, Faculté de Médecine de Limoges, Limoges, France
U. Ringborg	Department of General Oncology, Karolinska Hospital, Stockholm, Sweden
M. Roselli	Department of Medical Oncology, University of Rome “Tor Vergata”, Rome, Italy
S.T. Rosen	Comprehensive Cancer Center & Beckman Research Institute, Duarte, CA, USA
M. Schauer	Visceral and Thoracic Surgery, Augusta Krankenhaus, Düsseldorf, Germany
M. Schneider	Department of Organic Chemistry, Bergische University, Wuppertal, Germany
J. Sehouli	Department of Gynecology with Center for Oncological Surgery, Charité Comprehensive Cancer Center (CCCC), Berlin, Germany
A. Seth	Laboratory of Molecular Pathology, Sunnybrook Research Institute and University of Toronto, Ontario, Canada
G. V. Sherbet	Cancer Research Unit, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, UK
A. Slominski	Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA
G.-I. Soma	Department of Integrated and Holistic Immunology, Faculty of Medicine, Kagawa University, Kagawa, Japan
G. S. Stein	Department of Biochemistry, College of Medicine, University of Vermont, Burlington, VT, USA
T. Stigbrand	Department of Immunology, Umeå University, Umeå, Sweden
T. M. Theophanides	Department of Chemistry, Technical University of Athens, Athens, Greece
P. M. Ueland	Clinical Pharmacolocy Unit, Department of Pharmacology, University of Bergen, Bergen, Norway
H. Van Vlierberghe	Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium
R.G. Vile	Department of Immunology, Mayo Clinic, Rochester, MN, USA
M. Weller	Department of Neurology, University Hospital Zurich, Zurich, Switzerland
B. Westermark	Rudbecklaboratoriet, Department of Genetics and Pathology, University of Uppsala, Uppsala, Sweden
J. Westermarck	Center for Biotechnology, University of Turku, Turku, Finland
Y. Yen	Taipei Medical University, Taipei, Taiwan, ROC
M.R.I. Young	Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston, SC, USA
G.J. Delinasios	IIAR, Managing Editor
J.G. Delinasios	IIAR, Managing Editor (1981-2016)